The Food and Drug Administration (FDA) this week approved a blood test for colorectal cancer screening in average-risk adults aged 45 and older. Known as Shield, it is the first blood test to receive FDA approval as a primary screening method for colorectal cancer and to qualify for Medicare reimbursement, according to a press release. While the price has not been announced, the test is expected to reach the market within a week. Shield will …
Read More